David A Henderson

This inventor holds 21 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignee: Schering Aktiengesellschaft. Active years: 1985-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David A Henderson. Retrieved from https://idiyas.com/inventor/david-a-henderson-3fnxa96y

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 11

Forward Citations = 212(Granted Patents)

Company Filing History:

21 out of 1,409

Schering Aktiengesellschaft

patents

Years Active: 1985-1995

Loading Chart...

Areas of Expertise:

Aromatase Inhibitors

Steroid Derivatives

Cycloalkylene Azoles

N-Substituted Imidazoles

Pharmaceutical Preparations

Beta-Bridged Steroids

Androstenes

Estradienes

Pregnancy Test

Pharmaceutical Agents

Chemical Processes

Drug Manufacture

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5446178 - Process for preparing 19,11.beta.-bridged steroids (1995-08-29),

2. 5411982 - Cycloalkylene azoles, and their use as aromatase inhibitors (1995-05-02),

3. 5280035 - Cycloalkylene azoles and their use as aromatase inhibitors (1994-01-18),

4. 5145847 - 14,17.alpha.-etheno- and -ethanoestratrienes, processes for the (1992-09-08),

5. 5135937 - Cycloalkylene azoles and pharmaceutical preparations obtained therefrom (1992-08-04),

6. 5095129 - 19,11 .beta.-bridged steroids, their manufacture and pharmaceutical (1992-03-10),

7. 5089635 - 11 .beta.-phenyl-gonanes, their manufacture and pharmaceutical (1992-02-18),

8. 5089488 - .beta.-(4-isopropenylphenyl)estra-4,9-dienes, their production, and (1992-02-18),

9. 5045558 - N-substituted imidazoles and their use in pharmaceutical agents (1991-09-03),

10. 5021434 - N-substituted imidazoles, as well as their use in pharmaceutical agents (1991-06-04),

11. 4925834 - 3-methylene-4-androsten-17-ones, process for their production and (1990-05-15),

12. 4916144 - N-substituted imidazoles as aromatase inhibitors (1990-04-10),

13. 4877742 - Pregnancy test with EPF (1989-10-31),

14. 4871725 - 1-methyl-15.alpha.-(1-oxyalkyl)androsta-1,4-diene-3,17-diones, processes (1989-10-03),

15. 4870069 - 11.beta.-alkynyl-estrenes and -estradienes, their production and (1989-09-26),

Title: The Innovative Journey of David A Henderson

Introduction: David A Henderson is a pioneering inventor based in Berlin, Germany, known for his groundbreaking contributions to various fields through his inventive spirit and dedication to innovation.

Latest Patents: David A Henderson's latest patents include advancements in renewable energy technologies, smart home devices, and medical equipment, showcasing his versatility and forward-thinking approach to problem-solving.

Career Highlights: With a career spanning over two decades, David A Henderson has established himself as a prominent figure in the world of inventions. His notable achievements include the development of a revolutionary AI-powered transportation system and a patented method for sustainable waste management.

Collaborations: Throughout his career, David A Henderson has collaborated with leading research institutions, tech companies, and universities to bring his ideas to life. His collaborative efforts have resulted in cutting-edge solutions that have had a significant impact on various industries.

Conclusion: David A Henderson's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His work continues to inspire future generations to push the boundaries of what is possible through creativity and ingenuity.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]